Drug
PEG-based Laxative NER1006 clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 3
- first study started
- 2011
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
Often tested with
Tested in the same studies.
Polyethylene glycol 3350 (7) · Polyethylene Glycols (7) · MoviPrep (1)
Studies
Open first, then newest update. How each study uses PEG-based Laxative NER1006 is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Pharmacokinetic Study of PLENVU® in Healthy SubjectsCompletedPhase 1NorgineNCT03437265Written as PLENVU powder for oral solution
- Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among InpatientsStatus unknownPhase 4University of BolognaNCT04708366Written as NER1006
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.CompletedPhase 3NorgineNCT02273167Written as NER1006, 2-Day Split-Dosing
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in AdultsCompletedPhase 3NorgineNCT02254486Written as NER1006
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.CompletedPhase 3NorgineNCT02273141Written as NER1006, Day Before-Only Dosing
- Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening ColonoscopyCompletedPhase 2NorgineNCT01714466Written as NER1006
- Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy SubjectsCompletedPhase 1NorgineNCT01834742Written as NER1006